A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: suggest (285), remind (88)

Carboplatin-Docetaxel-Trastuzumab

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL-TRASTUZUMAB (TCH) Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel-Trastuzumab (TCH) Indication • Adjuvant treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Docetaxel-Trastuzumab.pdf

Capecitabine-TrastuzumabIV-Tucatinib

Description
Chemotherapy Protocol BREAST CANCER Capecitabine–Trastuzumab (IV)-Tucatinib Regimen • Breast Cancer – Capecitabine–Trastuzumab (IV)-Tucatinib Indication t • Treatment of over-expressed
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine-Trastuzumab-IV-Tucatinib.pdf

InP-ICE-Carboplatin-Etoposide-Ifosfamide

Description
Chemotherapy Protocol LYMPHOMA CARBOPLATIN-ETOPOSIDE-IFOSFAMIDE (ICE) Inpatient Regimen Regimen • Lymphoma – InP-ICE-Carboplatin-Etoposide-Ifosfamide Indication • Non Hodgkin’s Lymphoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-ICE-Carboplatin-Etoposide-Ifosfamide.pdf

InP (RICE) Carboplatin Etoposide Ifosfamide Rituximab

Description
Chemotherapy Protocol LYMPHOMA CARBOPLATIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RICE) Inpatient Regimen Regimen • Lymphoma – InP-RICE-Carboplatin-Etoposide-Ifosfamide-Rituximab Indication • Non Hodgkin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RICE-Carboplatin-Etoposide-Ifosfamide-Rituximab.pdf

AmB Carboplatin Etoposide Ifosfamide Rituximab (RICE)

Description
Chemotherapy Protocol LYMPHOMA CARBOPLATIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RICE) Ambulatory Regimen Regimen • Lymphoma – AmB-RICE-Carboplatin-Etoposide-Ifosfamide-Rituximab Indication • Non Hodgkin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-Carboplatin-Etoposide-Ifosfamide-Rituximab-RICE-Ver1.1.pdf

BEACON protocol v8.0 07Mar2023 signed

Description
A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf

Thalamotomy - patient information

Description
This factsheet explains what a thalamotomy is, what the procedure involves, and what the possible benefits and risks are.
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/Thalamotomy-3292-PIL.pdf

Capecitabine-Trastuzumab-SC-Tucatinib

Description
Chemotherapy Protocol BREAST CANCER Capecitabine– Trastuzumab (SC)-Tucatinib Regimen • Breast Cancer – Capecitabine–Trastuzumab (SC)-Tucatinib Indication • Treatment of over-expressed HER2
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine-Trastuzumab-SC-Tucatinib.pdf

Carboplatin(AUC6)Docetaxel

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel Indication • Neo-adjuvant or adjuvant treatment of triple
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CarboplatinAUC6Docetaxel.pdf

InP-Bleomycin-Cisplatin-Etoposide (5 day BEP) Ver1.2

Description
Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 5 Day) In-Patient Regimen Regimen Germ Cell – InP-Bleomycin-Cisplatin-Etoposide (5
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Bleomycin-Cisplatin-Etoposide-5-day-BEP-Ver1.2.pdf
71 to 80 of 117
Previous … 6 7 8 9 10 … Next